ESR1 and breast cancer: Some aspects of calcium signalling could be quite different between HER2+ and ER+ breast cancers and this could contribute to differences in the association between Cav3.2 levels and survival, for example Orai3-mediated Ca2+-influx is Ca2+-store dependent in ER positive but not ER negative breast cancer cells lines [61].